Acadian Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,067
| Closed | -$25K | – | 2028 |
|
|
2021
Q1 | $25K | Sell |
1,067
-5,554
| -84% | -$130K | ﹤0.01% | 1957 |
|
|
2020
Q4 | $133K | Sell |
6,621
-110,869
| -94% | -$2.23M | ﹤0.01% | 1665 |
|
|
2020
Q3 | $2.45M | Sell |
117,490
-143,320
| -55% | -$2.98M | 0.01% | 615 |
|
|
2020
Q2 | $4.56M | Sell |
260,810
-123,727
| -32% | -$2.16M | 0.02% | 507 |
|
|
2020
Q1 | $6.28M | Buy |
384,537
+129,695
| +51% | +$2.12M | 0.04% | 350 |
|
|
2019
Q4 | $5.24M | Buy |
254,842
+28,754
| +13% | +$592K | 0.02% | 427 |
|
|
2019
Q3 | $2.6M | Buy |
226,088
+9,557
| +4% | +$110K | 0.01% | 611 |
|
|
2019
Q2 | $2.85M | Buy |
216,531
+79,564
| +58% | +$1.05M | 0.01% | 521 |
|
|
2019
Q1 | $2.07M | Buy |
+136,967
| New | +$2.07M | 0.01% | 685 |
|
|
2018
Q1 | – | Sell |
-9,508
| Closed | -$176K | – | 1696 |
|
|
2017
Q4 | $176K | Buy |
+9,508
| New | +$176K | ﹤0.01% | 982 |
|